The New York Times reports (Elliott/Ives, 10/12/04) that the FDA is actually considering a proposal to loosen the rules on direct-to-consumer drug ads. The Times says the plan would let print ads be more "reader-friendly", concentrating on the most important or common side effects.
For the people who could get sick or die from the "less important" or more uncommon side effects, perhaps a "consumer friendly" or "consumer protection" approach would be in the public service more than merely a "reader friendly" emphasis.
Posted by schwitz at October 12, 2004 12:55 PM